Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 253

1.

Decrease of variation in the grading of dysplasia in colorectal adenomas with a national e-learning module.

Madani A, Kuijpers CCHJ, Sluijter CE, Von der Thüsen JH, Grünberg K, Lemmens VEPP, Overbeek LIH, Nagtegaal ID.

Histopathology. 2019 Feb 6. doi: 10.1111/his.13834. [Epub ahead of print]

PMID:
30725483
2.

Impact of Age and Comorbidity on Choice and Outcome of Two Different Treatment Options for Patients with Potentially Curable Esophageal Cancer.

Faiz Z, van Putten M, Verhoeven RHA, van Sandick JW, Nieuwenhuijzen GAP, van der Sangen MJC, Lemmens VEPP, Wijnhoven BPL, Plukker JTM.

Ann Surg Oncol. 2019 Feb 4. doi: 10.1245/s10434-019-07181-6. [Epub ahead of print]

PMID:
30719634
3.

A conditional model predicting the 10-year annual extra mortality risk compared to the general population: a large population-based study in Dutch breast cancer patients.

van Maaren MC, Kneepkens RF, Verbaan J, Huijgens PC, Lemmens VEPP, Verhoeven RHA, Siesling S.

PLoS One. 2019 Jan 24;14(1):e0210887. doi: 10.1371/journal.pone.0210887. eCollection 2019.

4.

Review: Pathology and Its Clinical Relevance of Mucinous Appendiceal Neoplasms and Pseudomyxoma Peritonei.

Legué LM, Creemers GJ, de Hingh IHJT, Lemmens VEPP, Huysentruyt CJ.

Clin Colorectal Cancer. 2018 Dec 6. pii: S1533-0028(18)30467-5. doi: 10.1016/j.clcc.2018.11.007. [Epub ahead of print] Review.

PMID:
30611664
5.

Association between primary origin (head, body and tail) of metastasised pancreatic ductal adenocarcinoma and oncologic outcome: A population-based analysis.

Mackay TM, van Erning FN, van der Geest LGM, de Groot JWB, Haj Mohammad N, Lemmens VE, van Laarhoven HW, Besselink MG, Wilmink JW; Dutch Pancreatic Cancer Group.

Eur J Cancer. 2019 Jan;106:99-105. doi: 10.1016/j.ejca.2018.10.008. Epub 2018 Nov 23.

PMID:
30476732
6.

Folic Acid and Vitamin B12 Supplementation and the Risk of Cancer: Long-term Follow-up of the B Vitamins for the Prevention of Osteoporotic Fractures (B-PROOF) Trial.

Oliai Araghi S, Kiefte-de Jong JC, van Dijk SC, Swart KMA, van Laarhoven HW, van Schoor NM, de Groot LCPGM, Lemmens V, Stricker BH, Uitterlinden AG, van der Velde N.

Cancer Epidemiol Biomarkers Prev. 2019 Feb;28(2):275-282. doi: 10.1158/1055-9965.EPI-17-1198. Epub 2018 Oct 19.

PMID:
30341095
7.

Association of the location of pancreatic ductal adenocarcinoma (head, body, tail) with tumor stage, treatment, and survival: a population-based analysis.

van Erning FN, Mackay TM, van der Geest LGM, Groot Koerkamp B, van Laarhoven HWM, Bonsing BA, Wilmink JW, van Santvoort HC, de Vos-Geelen J, van Eijck CHJ, Busch OR, Lemmens VE, Besselink MG; Dutch Pancreatic Cancer Group.

Acta Oncol. 2018 Dec;57(12):1655-1662. doi: 10.1080/0284186X.2018.1518593. Epub 2018 Sep 28.

PMID:
30264642
8.

Timing of postoperative chemotherapy in patients undergoing perioperative chemotherapy and gastrectomy for gastric cancer.

Brenkman HJF, van Putten M, Visser E, Verhoeven RHA, Nieuwenhuijzen GAP, Slingerland M, van Hillegersberg R, Lemmens VEPP, Ruurda JP.

Surg Oncol. 2018 Sep;27(3):421-427. doi: 10.1016/j.suronc.2018.05.026. Epub 2018 May 30.

PMID:
30217297
9.

Trends in treatment and survival of patients with nonresected, nonmetastatic pancreatic cancer: A population-based study.

van der Geest LGM, van Eijck CHJ, Groot Koerkamp B, Lemmens VEPP, Busch OR, Vissers PAJ, Wilmink JW, Besselink MG; Dutch Pancreatic Cancer Group.

Cancer Med. 2018 Oct;7(10):4943-4951. doi: 10.1002/cam4.1750. Epub 2018 Sep 6.

10.

Personalized management of elderly patients with rectal cancer: Expert recommendations of the European Society of Surgical Oncology, European Society of Coloproctology, International Society of Geriatric Oncology, and American College of Surgeons Commission on Cancer.

Montroni I, Ugolini G, Saur NM, Spinelli A, Rostoft S, Millan M, Wolthuis A, Daniels IR, Hompes R, Penna M, Fürst A, Papamichael D, Desai AM, Cascinu S, Gèrard JP, Myint AS, Lemmens VEPP, Berho M, Lawler M, De Liguori Carino N, Potenti F, Nanni O, Altini M, Beets G, Rutten H, Winchester D, Wexner SD, Audisio RA.

Eur J Surg Oncol. 2018 Nov;44(11):1685-1702. doi: 10.1016/j.ejso.2018.08.003. Epub 2018 Aug 15. Review.

PMID:
30150158
11.

Overall survival before and after centralization of gastric cancer surgery in the Netherlands.

van Putten M, Nelen SD, Lemmens VEPP, Stoot JHMB, Hartgrink HH, Gisbertz SS, Spillenaar Bilgen EJ, Heisterkamp J, Verhoeven RHA, Nieuwenhuijzen GAP.

Br J Surg. 2018 Dec;105(13):1807-1815. doi: 10.1002/bjs.10931. Epub 2018 Aug 22.

PMID:
30132789
12.

Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study.

Huang L, Jansen L, Balavarca Y, Babaei M, van der Geest L, Lemmens V, Van Eycken L, De Schutter H, Johannesen TB, Primic-Žakelj M, Zadnik V, Besselink MG, Schrotz-King P, Brenner H.

BMC Med. 2018 Aug 21;16(1):125. doi: 10.1186/s12916-018-1120-9.

13.

An overview of 25 years of incidence, treatment and outcome of colorectal cancer patients.

Brouwer NPM, Bos ACRK, Lemmens VEPP, Tanis PJ, Hugen N, Nagtegaal ID, de Wilt JHW, Verhoeven RHA.

Int J Cancer. 2018 Dec 1;143(11):2758-2766. doi: 10.1002/ijc.31785. Epub 2018 Sep 29.

14.

Unknown primary carcinoma in the Netherlands: decrease in incidence and survival times remain poor between 2000 and 2012.

Schroten-Loef C, Verhoeven RHA, de Hingh IHJT, van de Wouw AJ, van Laarhoven HWM, Lemmens VEPP.

Eur J Cancer. 2018 Sep;101:77-86. doi: 10.1016/j.ejca.2018.06.032. Epub 2018 Jul 20.

PMID:
30031970
15.

Oncologic treatment strategies and relative survival of patients with stage I-III rectal cancer - A EURECCA international comparison between the Netherlands, Belgium, Denmark, Sweden, England, Ireland, Spain, and Lithuania.

Breugom AJ, Bastiaannet E, Boelens PG, Van Eycken E, Iversen LH, Martling A, Johansson R, Evans T, Lawton S, O'Brien KM, Ortiz H, Janciauskiene R, Dekkers OM, Rutten HJT, Liefers GJ, Lemmens VEPP, van de Velde CJH.

Eur J Surg Oncol. 2018 Sep;44(9):1338-1343. doi: 10.1016/j.ejso.2018.05.025. Epub 2018 May 26.

PMID:
29960770
16.

Nonsurgical therapies for resected and unresected pancreatic cancer in Europe and USA in 2003-2014: a large international population-based study.

Huang L, Jansen L, Balavarca Y, van der Geest L, Lemmens V, Van Eycken L, De Schutter H, Johannesen TB, Primic-Žakelj M, Zadnik V, Mägi M, Pulte D, Schrotz-King P, Brenner H.

Int J Cancer. 2018 Dec 15;143(12):3227-3239. doi: 10.1002/ijc.31628. Epub 2018 Oct 3.

PMID:
29923613
17.

Patient characteristics and treatment considerations in pancreatic cancer: a population based study in the Netherlands.

Zijlstra M, van der Geest LGM, van Laarhoven HWM, Lemmens VEPP, van de Poll-Franse LV, Raijmakers NJH.

Acta Oncol. 2018 Sep;57(9):1185-1191. doi: 10.1080/0284186X.2018.1470330. Epub 2018 May 9.

PMID:
29741436
18.

Clinical lymph node staging in colorectal cancer; a flip of the coin?

Brouwer NPM, Stijns RCH, Lemmens VEPP, Nagtegaal ID, Beets-Tan RGH, Fütterer JJ, Tanis PJ, Verhoeven RHA, de Wilt JHW.

Eur J Surg Oncol. 2018 Aug;44(8):1241-1246. doi: 10.1016/j.ejso.2018.04.008. Epub 2018 Apr 17.

PMID:
29739638
19.

Morbidity and mortality according to age following gastrectomy for gastric cancer.

Nelen SD, Bosscha K, Lemmens VEPP, Hartgrink HH, Verhoeven RHA, de Wilt JHW; Dutch Upper Gastrointestinal Cancer Audit group.

Br J Surg. 2018 Aug;105(9):1163-1170. doi: 10.1002/bjs.10836. Epub 2018 Apr 23.

PMID:
29683186
20.

Nationwide trends in the incidence and outcome of patients with gastrointestinal stromal tumour in the imatinib era.

van der Graaf WTA, Tielen R, Bonenkamp JJ, Lemmens V, Verhoeven RHA, de Wilt JHW.

Br J Surg. 2018 Jul;105(8):1020-1027. doi: 10.1002/bjs.10809. Epub 2018 Apr 17.

21.

[Hospital of diagnosis influences the probability of receiving curative treatment for oesophageal and gastric cancer].

van Putten M, Verhoeven RHA, Koëter M, van Laarhoven HWM, van Sandick JW, Plukker JTM, Siersema PD, Hulshof MCCM, Wijnhoven BPL, Lemmens VEPP, Nieuwenhuijzen GAP.

Ned Tijdschr Geneeskd. 2018;162:D1970. Dutch.

PMID:
29600921
22.

Long-term survival improvement in oesophageal cancer in the Netherlands.

van Putten M, de Vos-Geelen J, Nieuwenhuijzen GAP, Siersema PD, Lemmens VEPP, Rosman C, van der Sangen MJC, Verhoeven RHA.

Eur J Cancer. 2018 May;94:138-147. doi: 10.1016/j.ejca.2018.02.025. Epub 2018 Mar 20.

PMID:
29571082
23.

Definitive chemoradiation or surgery in elderly patients with potentially curable esophageal cancer in the Netherlands: a nationwide population-based study on patterns of care and survival.

Koëter M, van Putten M, Verhoeven RHA, Lemmens VEPP, Nieuwenhuijzen GAP.

Acta Oncol. 2018 Sep;57(9):1192-1200. doi: 10.1080/0284186X.2018.1450521. Epub 2018 Mar 12.

PMID:
29528262
24.

A Population-based Study on Lymph Node Retrieval in Patients with Esophageal Cancer: Results from the Dutch Upper Gastrointestinal Cancer Audit.

van der Werf LR, Dikken JL, van Berge Henegouwen MI, Lemmens VEPP, Nieuwenhuijzen GAP, Wijnhoven BPL; Dutch Upper GI Cancer Audit group.

Ann Surg Oncol. 2018 May;25(5):1211-1220. doi: 10.1245/s10434-018-6396-7. Epub 2018 Mar 9.

25.

[National population screening for colorectal carcinoma in the Netherlands: results of the first years since the implementation in 2014].

Elferink MAG, Toes-Zoutendijk E, Vink GR, Lansdorp-Vogelaar I, Meijer GA, Dekker E, Lemmens VEPP.

Ned Tijdschr Geneeskd. 2018;162:D2283. Dutch.

PMID:
29519262
26.

Treatment and outcome of elderly patients with advanced stage ovarian cancer: A nationwide analysis.

Schuurman MS, Kruitwagen RFPM, Portielje JEA, Roes EM, Lemmens VEPP, van der Aa MA.

Gynecol Oncol. 2018 May;149(2):270-274. doi: 10.1016/j.ygyno.2018.02.017. Epub 2018 Mar 4.

PMID:
29514738
27.

Crosstalk-free multicolor RICS using spectral weighting.

Schrimpf W, Lemmens V, Smisdom N, Ameloot M, Lamb DC, Hendrix J.

Methods. 2018 May 1;140-141:97-111. doi: 10.1016/j.ymeth.2018.01.022. Epub 2018 Feb 22.

PMID:
29408283
28.

Administration of adjuvant chemotherapy for stage II-III colon cancer patients: An European population-based study.

Babaei M, Balavarca Y, Jansen L, Lemmens V, van Erning FN, van Eycken L, Vaes E, Sjövall A, Glimelius B, Ulrich CM, Schrotz-King P, Brenner H.

Int J Cancer. 2018 Apr 1;142(7):1480-1489. doi: 10.1002/ijc.31168. Epub 2017 Dec 4.

29.

Treatment and Outcome of Synchronous Colorectal Carcinomas: A Nationwide Study.

Bos ACRK, Matthijsen RA, van Erning FN, van Oijen MGH, Rutten HJT, Lemmens VEPP.

Ann Surg Oncol. 2018 Feb;25(2):414-421. doi: 10.1245/s10434-017-6255-y. Epub 2017 Nov 20.

PMID:
29159744
30.

Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations.

Huang L, Jansen L, Balavarca Y, Molina-Montes E, Babaei M, van der Geest L, Lemmens V, Van Eycken L, De Schutter H, Johannesen TB, Fristrup CW, Mortensen MB, Primic-Žakelj M, Zadnik V, Becker N, Hackert T, Mägi M, Cassetti T, Sassatelli R, Grützmann R, Merkel S, Gonçalves AF, Bento MJ, Hegyi P, Lakatos G, Szentesi A, Moreau M, van de Velde T, Broeks A, Sant M, Minicozzi P, Mazzaferro V, Real FX, Carrato A, Molero X, Besselink MG, Malats N, Büchler MW, Schrotz-King P, Brenner H.

Gut. 2019 Jan;68(1):130-139. doi: 10.1136/gutjnl-2017-314828. Epub 2017 Nov 20.

PMID:
29158237
31.

Evaluation of Guideline Adherence in Colorectal Cancer Treatment in The Netherlands: A Survey Among Medical Oncologists by the Dutch Colorectal Cancer Group.

Keikes L, van Oijen MGH, Lemmens VEPP, Koopman M, Punt CJA.

Clin Colorectal Cancer. 2018 Mar;17(1):58-64. doi: 10.1016/j.clcc.2017.10.007. Epub 2017 Nov 20.

32.

In Reply: Centralization of Upper Gastrointestinal Cancer Care Should Be Dictated by Quality of Care.

Henneman D, Dikken JL, Putter H, Lemmens VEPP, Van der Geest LGM, van Hillegersberg R, Verheij M, van de Velde CJH, Wouters MWJM.

Ann Surg Oncol. 2017 Dec;24(Suppl 3):621-622. doi: 10.1245/s10434-017-6222-7. Epub 2017 Nov 13. No abstract available.

PMID:
29134375
33.

Synchronous peritoneal metastases of small bowel adenocarcinoma: Insights into an underexposed clinical phenomenon.

Legué LM, Simkens GA, Creemers GM, Lemmens VEPP, de Hingh IHJT.

Eur J Cancer. 2017 Dec;87:84-91. doi: 10.1016/j.ejca.2017.10.012. Epub 2017 Nov 10.

PMID:
29132061
34.

Neoadjuvant Therapy in Rectal Cancer Patients With Clinical Stage II to III Across European Countries: Variations and Outcomes.

Babaei M, Jansen L, Balavarca Y, Sjövall A, Bos A, van de Velde T, Moreau M, Liberale G, Gonçalves AF, Bento MJ, Ulrich CM, Schrotz-King P, Lemmens V, Glimelius B, Brenner H.

Clin Colorectal Cancer. 2018 Mar;17(1):e129-e142. doi: 10.1016/j.clcc.2017.09.002. Epub 2017 Sep 28.

35.

Stage distribution of screen-detected colorectal cancers in the Netherlands.

Toes-Zoutendijk E, Kooyker AI, Elferink MA, Spaander MCW, Dekker E, Koning HJ, Lemmens VE, van Leerdam ME, Lansdorp-Vogelaar I; LECO working group.

Gut. 2018 Sep;67(9):1745-1746. doi: 10.1136/gutjnl-2017-315111. Epub 2017 Oct 21. No abstract available.

PMID:
29055907
36.

Nationwide trends in chemotherapy use and survival of elderly patients with metastatic pancreatic cancer.

van der Geest LGM, Haj Mohammad N, Besselink MGH, Lemmens VEPP, Portielje JEA, van Laarhoven HWM, Wilmink JHW; Dutch Pancreatic Cancer Group.

Cancer Med. 2017 Dec;6(12):2840-2849. doi: 10.1002/cam4.1240. Epub 2017 Oct 16.

37.

Evaluating the scientific basis of quality indicators in colorectal cancer care: A systematic review.

Keikes L, Koopman M, Tanis PJ, Lemmens VEPP, Punt CJA, van Oijen MGH.

Eur J Cancer. 2017 Nov;86:166-177. doi: 10.1016/j.ejca.2017.08.034. Epub 2017 Oct 6. Review.

PMID:
28988017
38.

Nationwide outcomes in patients undergoing surgical exploration without resection for pancreatic cancer.

van der Geest LGM, Lemmens VEPP, de Hingh IHJT, van Laarhoven CJHM, Bollen TL, Nio CY, van Eijck CHJ, Busch ORC, Besselink MG; Dutch Pancreatic Cancer Group.

Br J Surg. 2017 Oct;104(11):1568-1577. doi: 10.1002/bjs.10602. Epub 2017 Aug 22.

PMID:
28832964
39.

Adjuvant Chemoradiotherapy for Non-Pretreated Gastric Cancer.

Ho VKY, Jansen EPM, Wijnhoven BPL, Neelis KJ, van Sandick JW, Verhoeven RHA, Lemmens VEP, van Laarhoven HWM.

Ann Surg Oncol. 2017 Nov;24(12):3647-3657. doi: 10.1245/s10434-017-6048-3. Epub 2017 Aug 22.

PMID:
28831737
40.

Effect of age on rates of palliative surgery and chemotherapy use in patients with locally advanced or metastatic gastric cancer.

Nelen SD, van Putten M, Lemmens VEPP, Bosscha K, de Wilt JHW, Verhoeven RHA.

Br J Surg. 2017 Dec;104(13):1837-1846. doi: 10.1002/bjs.10621. Epub 2017 Aug 9.

PMID:
28791679
41.

Nationwide comprehensive gastro-intestinal cancer cohorts: the 3P initiative.

Coebergh van den Braak RRJ, van Rijssen LB, van Kleef JJ, Vink GR, Berbee M, van Berge Henegouwen MI, Bloemendal HJ, Bruno MJ, Burgmans MC, Busch ORC, Coene PPLO, Coupé VMH, Dekker JWT, van Eijck CHJ, Elferink MAG, Erdkamp FLG, van Grevenstein WMU, de Groot JWB, van Grieken NCT, de Hingh IHJT, Hulshof MCCM, Ijzermans JNM, Kwakkenbos L, Lemmens VEPP, Los M, Meijer GA, Molenaar IQ, Nieuwenhuijzen GAP, de Noo ME, van de Poll-Franse LV, Punt CJA, Rietbroek RC, Roeloffzen WWH, Rozema T, Ruurda JP, van Sandick JW, Schiphorst AHW, Schipper H, Siersema PD, Slingerland M, Sommeijer DW, Spaander MCW, Sprangers MAG, Stockmann HBAC, Strijker M, van Tienhoven G, Timmermans LM, Tjin-A-Ton MLR, van der Velden AMT, Verhaar MJ, Verkooijen HM, Vles WJ, de Vos-Geelen JMPGM, Wilmink JW, Zimmerman DDE, van Oijen MGH, Koopman M, Besselink MGH, van Laarhoven HWM; Dutch Pancreatic Cancer Group, Dutch Upper GI Cancer Group and PLCRC working group.

Acta Oncol. 2018 Feb;57(2):195-202. doi: 10.1080/0284186X.2017.1346381. Epub 2017 Jul 19.

PMID:
28723307
42.

Volume-outcome relation in palliative systemic treatment of metastatic oesophagogastric cancer.

Haj Mohammad N, Bernards N, van Putten M, Lemmens VEPP, van Oijen MGH, van Laarhoven HWM.

Eur J Cancer. 2017 Jun;78:28-36. doi: 10.1016/j.ejca.2017.03.008. Epub 2017 Apr 14.

PMID:
28412586
43.

The difference in association between aspirin use and other thrombocyte aggregation inhibitors and survival in patients with colorectal cancer.

Frouws MA, Rademaker E, Bastiaannet E, van Herk-Sukel MPP, Lemmens VE, Van de Velde CJH, Portielje JEA, Liefers GJ.

Eur J Cancer. 2017 May;77:24-30. doi: 10.1016/j.ejca.2017.02.025. Epub 2017 Mar 26.

PMID:
28350995
44.

Increasing survival gap between young and elderly gastric cancer patients.

Nelen SD, Verhoeven RHA, Lemmens VEPP, de Wilt JHW, Bosscha K.

Gastric Cancer. 2017 Nov;20(6):919-928. doi: 10.1007/s10120-017-0708-7. Epub 2017 Mar 9.

45.

Socio-economic status influences the likelihood of undergoing surgical treatment for pancreatic cancer in the Netherlands.

Bakens MJAM, Lemmens VEPP, de Hingh IHJT.

HPB (Oxford). 2017 May;19(5):443-448. doi: 10.1016/j.hpb.2017.01.010. Epub 2017 Feb 20.

46.

Survival of patients with colorectal peritoneal metastases is affected by treatment disparities among hospitals of diagnosis: A nationwide population-based study.

Rovers KP, Simkens GA, Vissers PA, Lemmens VE, Verwaal VJ, Bremers AJ, Wiezer MJ, Burger JW, Hemmer PH, Boot H, van Grevenstein WM, Meijerink WJ, Aalbers AG, Punt CJ, Tanis PJ, de Hingh IH; Dutch Peritoneal Oncology Group (DPOG).

Eur J Cancer. 2017 Apr;75:132-140. doi: 10.1016/j.ejca.2016.12.034. Epub 2017 Feb 20.

PMID:
28222307
47.

Peritoneal Metastases from Gastroenteropancreatic Neuroendocrine Tumors: Incidence, Risk Factors and Prognosis.

Madani A, Thomassen I, van Gestel YRBM, van der Bilt JDW, Haak HR, de Hingh IHJT, Lemmens VEPP.

Ann Surg Oncol. 2017 Aug;24(8):2199-2205. doi: 10.1245/s10434-016-5734-x. Epub 2017 Feb 15.

PMID:
28204963
48.

The Influence of BRAF and KRAS Mutation Status on the Association between Aspirin Use and Survival after Colon Cancer Diagnosis.

Frouws MA, Reimers MS, Swets M, Bastiaannet E, Prinse B, van Eijk R, Lemmens VE, van Herk-Sukel MP, van Wezel T, Kuppen PJ, Morreau H, van de Velde CJ, Liefers GJ.

PLoS One. 2017 Jan 26;12(1):e0170775. doi: 10.1371/journal.pone.0170775. eCollection 2017.

49.

Effect of low-dose aspirin use on survival of patients with gastrointestinal malignancies; an observational study.

Frouws MA, Bastiaannet E, Langley RE, Chia WK, van Herk-Sukel MP, Lemmens VE, Putter H, Hartgrink HH, Bonsing BA, Van de Velde CJ, Portielje JE, Liefers GJ.

Br J Cancer. 2017 Jan;116(3):405-413. doi: 10.1038/bjc.2016.425. Epub 2017 Jan 10.

50.

Underestimation of pancreatic cancer in the national cancer registry - Reconsidering the incidence and survival rates.

Fest J, Ruiter R, van Rooij FJ, van der Geest LG, Lemmens VE, Ikram MA, Coebergh JW, Stricker BH, van Eijck CH.

Eur J Cancer. 2017 Feb;72:186-191. doi: 10.1016/j.ejca.2016.11.026. Epub 2016 Dec 26.

PMID:
28033529

Supplemental Content

Loading ...
Support Center